Seroprevalence of Covid-19 in the Staff of the University Hospitals of Strasbourg
- Conditions
- COVID-19
- Registration Number
- NCT05652582
- Lead Sponsor
- University Hospital, Strasbourg, France
- Brief Summary
The Grand Est region is one of the most affected regions in France during the first wave of the COVID-19 epidemic. A significant increase in the number of patients hospitalized for SARS-CoV 2 infection at the University Hospitals of Strasbourg (HUS) led to a sudden saturation of their capacities. Hospital workers appear to be a population at particular risk for this new infectious agent. The percentage of hospital workers who have been in contact with the virus or have contracted COVID-19 is unknown.
The objective of this work is to determine the prevalence of SARS-CoV-2 positive serologies among hospital staff screened from June 22, 2020 to November 1, 2020 following a screening campaign offering serological testing to all volunteer HUS professionals.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 5694
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the positive seroprevalence of SARS-CoV-2 among hospital staff screened from June 22, 2020 to November 1, 2020 Files analysed retrospectively from June 22, 2020 to November 1, 2020 will be examined Seroprevalence will be estimated by calculating the rate of seropositive subjects with its 95% confidence interval
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Service Laboratoire de Virologie - PTM - CHU de Strasbourg - France
🇫🇷Strasbourg, France